Our Platform
Find out how KOSMAS has become the only biotech to develop proprietary Trilyte technologies.
The Team
Meet the team of founders, scientists & advisors behind the paradigm-changing research.
In the News
Read the proof of our leading research in multiple publications across the scientific world.
We help combat disease & stop it in its tracks.
Our innovative products go beyond targeted agents and killer cell-mediated therapies. We have developed a patent-protected technology for the design of Trilyte molecules with more effective targeting of cancer stem cells and greater anti-cancer efficacy than competing agents.
Currently, KOSMAS is the only company producing Trilytes in a format that combines “dual-targeting” of the cancer cell with an active engagement of killer cells, which promises to become a leading strategy for cancer therapy.